Essenvia
PrivateLast Round
Series A
Nov 15, 2023
Total Funding Raised
$4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Essenvia operates in Enterprise Software and is based in Los Angeles, California. Its latest recorded funding round was a Series A round in November 2023.
Essenvia is a health-tech company that provides an AI-powered regulatory information management platform to streamline medical device regulatory submissions and lifecycle management.
Sector
Enterprise Software
Verticals
Vertical SaaS, Medical Devices, Compliance & Risk, RegTech, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Essenvia Comparables
Compare Essenvia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rimsys | 93% | |
| RegDesk | 84% | |
| Cruxi | 83% |
For institutional investors. Book with your work email.
Essenvia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 15, 2023 | ||||
| Seed | May 2, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Essenvia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wavemaker Three-Sixty Health | Seed |
| Rebright Partners | Seed |
| Pasadena Angels | Seed |
| First Rays Venture Partners | Seed |
| Benhamou Global Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 69% MoM, reaching 3.8K.
- Nov 7, 2025
Monthly visitors increased 130% MoM, reaching 3.3K.
For institutional investors. Book with your work email.
Essenvia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Essenvia's valuation, stock price, and market status.
Is Essenvia a public or private company?
Essenvia is a private company.
What is the current stock price of Essenvia?
Essenvia is a private company, so its shares have no public market price. Caplight tracks Essenvia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Essenvia worth (valuation)?
Valuation information for Essenvia is not publicly available.
Can I buy Essenvia stock?
Essenvia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Essenvia's last funding round?
Essenvia's most recent funding round was Series A on November 15, 2023.
Who are the main investors in Essenvia?
Key investors in Essenvia include Wavemaker Three-Sixty Health, Benhamou Global Ventures.
Will Essenvia IPO soon?
No public IPO plans have been announced for Essenvia.
How can I track Essenvia secondary market activity?
Caplight tracks bids, offers, and trades in Essenvia's shares on secondary markets.